Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthis Synofzik

Showing results (91-100 of 511) with videos related to

Pageof 52
Sort By:
Biochemical and Biophysical Research Communications|July 30, 2015
Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia/cerebellar ataxia (SPG46)Saki Sultana, Jennifer Reichbauer, Rebecca Schüle, et al.
Plos One|June 30, 2017
Absence of EEG correlates of self-referential processing depth in ALSTatiana Fomina, Sebastian Weichwald, Matthis Synofzik, et al.
Dysphagia|January 10, 2018
Validation and Psychometric Properties of the German Version of the SWAL-QOLEva-Maria Kraus, Natalie Rommel, Lisa H Stoll, et al.
Journal of Neurology|May 9, 2018
Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot studyCarlo Wilke, Friedemann Bender, Stefanie N Hayer, et al.
Molecular Therapy. Nucleic Acids|July 29, 2025
Tailored antisense oligonucleotides for ultrarare CNS diseases: An experience-based best practice framework for individual patient evaluationRebecca Schüle, Holm Graessner, Annemieke Aartsma-Rus, et al.
Journal of Neurology|March 10, 2026
Development and validation of the dysarthria impact scale: a patient-reported outcome for motor speech disordersAdam P Vogel, Lisa Graf, Merit Weiß, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 13, 2020
Multifocal, hypoechogenic nerve thickening in Cerebrotendinous XanthomatosisBenjamin Roeben, Jennifer Just, Holger Hengel, et al.
Parkinsonism & Related Disorders|June 19, 2018
Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonismMilan Zimmermann, Carlo Wilke, Claudia Schulte, et al.
Neurology. Clinical Practice|September 6, 2021
Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled TrialCarolin Muth, Julian Teufel, Ludger Schöls, et al.
Cerebellum (London, England)|January 15, 2013
Friedreich ataxia: dysarthria profile and clinical dataBettina Brendel, Hermann Ackermann, Daniela Berg, et al.
Pageof 52

Showing results (91-100 of 511) with videos related to

Sort By:
Pageof 52
Biochemical and Biophysical Research Communications|July 30, 2015
Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia/cerebellar ataxia (SPG46)Saki Sultana, Jennifer Reichbauer, Rebecca Schüle, et al.
Plos One|June 30, 2017
Absence of EEG correlates of self-referential processing depth in ALSTatiana Fomina, Sebastian Weichwald, Matthis Synofzik, et al.
Dysphagia|January 10, 2018
Validation and Psychometric Properties of the German Version of the SWAL-QOLEva-Maria Kraus, Natalie Rommel, Lisa H Stoll, et al.
Journal of Neurology|May 9, 2018
Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot studyCarlo Wilke, Friedemann Bender, Stefanie N Hayer, et al.
Molecular Therapy. Nucleic Acids|July 29, 2025
Tailored antisense oligonucleotides for ultrarare CNS diseases: An experience-based best practice framework for individual patient evaluationRebecca Schüle, Holm Graessner, Annemieke Aartsma-Rus, et al.
Journal of Neurology|March 10, 2026
Development and validation of the dysarthria impact scale: a patient-reported outcome for motor speech disordersAdam P Vogel, Lisa Graf, Merit Weiß, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 13, 2020
Multifocal, hypoechogenic nerve thickening in Cerebrotendinous XanthomatosisBenjamin Roeben, Jennifer Just, Holger Hengel, et al.
Parkinsonism & Related Disorders|June 19, 2018
Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonismMilan Zimmermann, Carlo Wilke, Claudia Schulte, et al.
Neurology. Clinical Practice|September 6, 2021
Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled TrialCarolin Muth, Julian Teufel, Ludger Schöls, et al.
Cerebellum (London, England)|January 15, 2013
Friedreich ataxia: dysarthria profile and clinical dataBettina Brendel, Hermann Ackermann, Daniela Berg, et al.
Pageof 52